key: cord-0774539-zf8etc12
authors: Makadzange, A. T.; Lau, C.; Dietrich, J.; Hlupeni, A.; Myburgh, N.; Gundidza, P.; Elose, N.; Madhi, S.; James, W.; Stanberry, L.; Ndhlovu, C. E.
title: Investigating Attitudes, Motivations and Key Influencers for vaccine uptake among late adopters of COVID-19 vaccination in Africa
date: 2022-04-21
journal: nan
DOI: 10.1101/2022.04.20.22274081
sha: 4cc2ad68923f7f915e9c05ccfb5eaeedc7ce1c19
doc_id: 774539
cord_uid: zf8etc12

Background: The rapid development of vaccines in response to the COVID-19 pandemic has provided an effective tool for the management of COVID-19. In Africa COVID-19 vaccine uptake is poor; with 15% vaccine coverage compared to the WHO target of 70%. An important factor has been vaccine hesitancy, understanding late adopters of vaccination can provide insights into the attitudes, motivations and influences that can enhance vaccine uptake. Methods: Between January 4 - February 11, 2022, we conducted a survey among adults presenting for their first dose of a COVID-19 vaccine almost 12-months after the vaccination program began. Vaccines were free and provided at clinics and outreach centers in Harare, Zimbabwe. The questionnaire assessed environmental and individual factors (attitudes, barriers, motivations, key influencers, and information sources) that influenced the decision to present for vaccination. Baseline socio-demographic data and responses to survey questions were summarized using descriptive statistics. Binary logistic regression models were developed to understand factors associated with vaccine confidence. Results: 1016 adults were enrolled into the study, 508 (50%) were female, 126 (12.4%) had HIV co-infection. The median age was 30 years (IQR 22 - 39). Women were more likely to have negative views about the COVID-19 vaccine compared to men (OR 1.51 (95%CI 1.16, 1.97, p=0.002). Women compared to men and older adults (>= 40 years) compared with youth (18-25 years) were more likely to have major concerns about vaccines. Most concerns were about safety with 602 (59.3%) concerned about immediate and 520 (51.2%) about long-term health effects of vaccines. People living with HIV (PLWH) were more likely to perceive vaccines as safe (OR 1.71 (95%CI: 1.07, 2.74, p=0.025), effective (1.68 (95%CI: 1.07, 2.64, p=0.026) and to trust regulatory systems for approving vaccines (OR 1.79 (95% CI: 1.11, 2.89, p=0.017) compared to those without HIV. Internet users were less likely to perceive vaccines as safe (OR 0.72 (95% CI: 0.55, 0.95, p=0.021), effective (OR 0.61 (95% CI: 0.47, 0.80, p<0.001) or trust regulatory processes for approving vaccines (OR 0.64 (95% CI: 0.48, 0.85, p=0.002) compared to non-internet users. Social influence was a key factor in the decision to be vaccinated with family members being the primary key influencers for 560 (55.2%) participants. The most important reason for receiving the COVID-19 vaccine today for 715 (70.4%) participants was the protection of individual health. The most trusted source of information regarding the vaccine was the Ministry of Health (79.7%) and the radio, television and social media were the preferred sources for obtaining this information. Social media was a more likely source for youth and those with higher levels of education. Conclusion: Improving vaccine coverage will need targeted communication strategies that address negative perceptions of vaccines and associated safety and effectiveness concerns. Leveraging normative behavior as a social motivator for vaccination will be important as close social networks are key influences of vaccination. Traditional media remains important for health communication in Africa and should be strengthened to counter social media-based misinformation that drives concerns about safety and effectiveness particularly among internet users.

115 The questionnaire consisted of six main sections including demographics (sex, age, education, 116 socio-economic status), attitudes and views towards COVID-19 vaccines, barriers, motivations, 117 information sources and vaccination experience (Table 1) . Age was categorized into 3 groups:

118 ages 18-25 as youth, 26-39 years as young adults and ≥ 40 years as older adults. Vaccine 119 confidence was measured through survey statements related to individual perception on safety, 120 effectiveness of vaccines and confidence in country's regulatory approval process for vaccines 121 (14) ( Table 1) . Socioeconomic status was based on an assessment of available resources -122 electricity, television, refrigerator, bed, battery or generator for power. High socioeconomic 123 status was defined by owning both a battery or a generator for power and a refrigerator, low 124 economic status was defined by neither owning a refrigerator or alternative source of power. In 125 addition, internet usage in the last 30 days, was assessed.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 21, 2022. ; https://doi.org/10.1101/2022.04.20.22274081 doi: medRxiv preprint 127 Table 1 . Survey questions addressing Vaccine convenience and confidence (Full study 128 questionnaire included in appendix)

Response options Vaccine convenience How long did it take you to travel to this vaccination site today?

Less than 15 minutes; 15-30 minutes; 31-60 minutes; 1-2 hours; More than 2 hours; Don't know; Prefer not to answer From the time you arrived at the vaccination site, how long did it take you to get your vaccine shot?

Less than 10 minutes; 10-20 minutes; 20-30 minutes; 30-60 minutes; More than 60 minutes; Not applicable How easy or difficult was it to register for a vaccination appointment? is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 21, 2022. ; https://doi.org/10.1101/2022.04.20.22274081 doi: medRxiv preprint 154 Hospital, the University of Zimbabwe, and Harare City Health Departments prior to initiation of 155 the study. All amendments to the protocol, consent forms and/or recruitment materials were 156 approved by the institutional review boards before they were implemented. All participants 157 provided written informed consent. 168 participants. Ownership of these resources was used to classify participants as high, middle, or 169 low socioeconomic status (Table 1) . Among study participants 428 (42.1%) reported knowing 170 someone who was seriously ill or died from COVID-19 disease; these were close relatives (e.g., 171 siblings, spouse or parents) in 30% of respondents. Internet use in the past 30 days was reported 172 by 420 (41.4%) participants (Table2).

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 21, 2022.

174 186 to receive the shot after arrival was less than 10 minutes for 338 (33.3%) and less than an hour . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 21, 2022. 223 0.53-0.91, p=0.007)) or major concerns (OR 0.69 (95%CI: 0.52-0.91, p=0.009)) compared to those 224 who did not (Tables 3 and 4 ).

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 21, 2022. 229 Immediate health concerns were a concern for 602 (59.3%) and long-term health effects for 520, 230 (51.2%) (Figure 1 ). Young adults compared to youth (OR 1.48 (95%CI: 1.11, 1.98), p=0.008) and

231 PLWH (OR 1.56 (95%CI: 1.05-2.23, p=0.029) compared to those without were more likely to 232 express concerns about immediate side effects (Table 4 ). Long-term health effects were a 233 particular concern for women compared to men, and young adults compared with youth ( 

238 The concern that 'the vaccine has not been tested enough' was expressed by 223 (21.9%), that (Table 5) .

245 Perceived vaccine safety was high with 728 (71.5%) participants strongly agreeing with the 246 statement "In general COVID-19 vaccines are safe" (Figure 2 ). The odds of strongly agreeing that 247 vaccines are safe decreased with education and internet use (Suppl Table 1 ). PLWH had higher 248 odds of perceiving vaccines as safe compared to those without HIV (OR 1.71 (95%CI: 1.07, 2.74, 249 p=0.025) (S1 Table) . Although most respondents felt that the Sinovac/Sinopharm vaccine was 250 either very safe (500 (49.2) or somewhat safe (175 (17.2%)), 311 (30.6%) indicated that they did 251 not know if the vaccine that had received was safe.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 21, 2022. 259 2). The odds that one perceived vaccine to be effective in preventing disease decreased with 260 increasing education and with internet use (S2 Table) . 263 vaccines were effective in preventing disease (S2 Table) 264 265 282 0.85, p=0.002) than those that had not used the internet in the last 30-days (S1-3 Table) .

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 21, 2022. ; https://doi.org/10.1101/2022.04.20.22274081 doi: medRxiv preprint 284 Key Influencers 285 Normative behavior can be a key motivator of vaccine uptake. The influence of others was 286 important with 684 (67.3%) participants indicating that they strongly agreed with the statement 287 "I came to get vaccinated because people important to me encouraged me to be vaccinated". In 288 addition, 702 (69.1%) of respondents strongly agreed with the statement "I came to get 289 vaccinated today because people important to me got a COVID-19 vaccine" (Figure 3a ). For 561 290 (55.2%) participants family members were the key influencers. Religious leaders (98, (9.7%)), 291 community leaders (56, (5.5%)), healthcare workers (133, (13.1%)) and co-workers (137 (13.5%)) 292 were less commonly listed as key influencers (figure 3b). 

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 21, 2022. ; https://doi.org/10.1101/2022.04.20.22274081 doi: medRxiv preprint 339 from television were twice as high in those with lower secondary (OR 2.22 (95%CI 1.39-3.56), 340 p=0.001) and higher secondary education (OR 2.72 (95%CI 1.35-5.48), p=0.005) than those with 341 primary education only (S5 Table) . Social media primarily WhatsApp and Facebook as a source of 342 information tracked strongly with age and education. Older adults had much lower odds of 343 obtaining information from WhatsApp (OR 0.41 (95% CI 0.3-0.58), p<0.001) (S6 Table) or 344 Facebook (OR 0.3 (95% CI (0.2-0.45), p<0.001) compared to youth (S7 Table) . Similarly, for those 345 with secondary and tertiary education compared to those with primary education (S6 Table) . 386 some studies suggesting that they may at best be like the general population(27, 28). However, 387 vaccination coverage targets for PLWH will likely need to be higher than those for the non-388 immunocompromised population, particularly in settings where many people are not on ART and 389 with high proportions of individuals with advanced HIV disease (29). Interestingly PLWH were . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 21, 2022. ; https://doi.org/10.1101/2022.04.20.22274081 doi: medRxiv preprint 390 more likely to perceive vaccines as safe and effective and trust government regulatory processes. 391 This may be because PLWH on chronic therapy interact with the healthcare system often and 392 have come to trust in and rely on the services.

394 Perceptions of safety, effectiveness and trust in regulatory authorities also tracked significantly 395 with education and income status. Those with higher education and better income resources 396 were less likely to perceive the vaccines as effective or trust in regulatory processes. This may be 397 an important trend to watch closely as the more educated and higher income individuals are 398 often key influencers in African families and communities. Ensuring that we design 399 communication strategies that effectively target these groups will be important, particularly as 400 their access of social media-based information and disinformation is also significantly higher. In 401 this study we observed that social influence was a key factor in the motivation to engage in is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 21, 2022. ; https://doi.org/10.1101/2022.04.20.22274081 doi: medRxiv preprint 415 low in many countries, we found in this study that trust in government as a source of information 416 on health and specifically COVID-19 was very high. Most participants cited the Ministry of Health 417 as top trusted sources of information. Building and maintaining that trust in Health Ministries and 418 regulatory processes will be critical in ensuring the success of COVID-19 and other vaccination 419 programs. 420 421 Traditional media -radio and television were the main media sources of information. Internet 422 based media sources were less commonly cited as major sources with only 41% of the cohort 423 using the internet over the last 30 days. Television and radio are largely state controlled providing 424 the authorities with an opportunity to disseminate accurate information on the safety and 425 effectiveness of vaccines. However social media particularly WhatsApp is growing in importance 426 and was an important source of information particularly for youth, and those with a higher 427 economic status and more education. Communication strategies to enhance vaccine uptake 428 should use both traditional and social media platforms but must be targeted by gender, age on 429 each medium to be most effective.

The study provides valuable insights into late adopters of vaccination in an African setting one 432 year after the national COVID-19 vaccination program began. Because we studied those that 433 made the decision to be vaccinated, this research does not provide insights into those that are 434 continuing to 'wait and see'. Although our understanding of those that are still on the sidelines of 435 vaccination is not yet enhanced that insights generated from this cohort will enable us to start to 436 effectively target the 'wait and see' population.

438 The study also focused on an urban population where access was not an issue. Further 439 understanding of barriers, motivations, and attitudes among rural populations in Africa will be . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 21, 2022. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 21, 2022. ; https://doi.org/10.1101/2022.04.20.22274081 doi: medRxiv preprint . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 21, 2022. ; https://doi.org/10.1101/2022.04.20.22274081 doi: medRxiv preprint

Appointments were not needed to receive the vaccine. Finding a vaccination site 188 was described as 'very easy' by 853 (84.2%), it was 'very easy' to get to the vaccination center for 189 889 (87.7%), it was 'very easy' to financially afford transportation to the site for 877 (86.5%) and 190 'very easy' to find a vaccination site with convenient hours for 786

477(47%) had 'very negative views' (Figure 1) and 198 (19.5%) had 198 'somewhat negative' views. Women were more likely than men (OR 1.51 (95% CI: 1.16,1.97, 199 p=0.002)) and young adults were more likely than youth

When vaccines first became available, what was your view towards COVID-19 204 vaccines?" and "It is common for people to be hesitant or unsure about getting 205 vaccinated. Did you ever have concerns about getting the COVID-19 vaccine?

The subsequent follow up question was "What is the most important reason you got 313 vaccinate today?

We asked the question 'In the past 30 days, who have you received information from about 317 COVID-19?'. Friend or family were the most common sources of information for 790

When asked the top 3 sources 320 of trusted information about COVID-19 vaccines the primary sources were the Ministry of Health 321 (79.7%), WHO (50.8%), local clinic (35%), local health authorities (31.1%), and friends or family 322 (22%) (Figure5). The WHO was a more important source of information for men than women 323 (50

0001) and religious leaders (56.3% and 34.8%, p<0.0001) among their top 3 trusted 325 sources for information. Doctors and other health professions were in the top 3 trusted sources 326 for 16.6% and 21.9% respectively

Sources and Trusted sources of information. Participants were asked "In the past 30 329 days, who have you received information from about COVID-19?" multiple responses were 330 allowed (Green). Participants were subsequently asked "What are your top 3 sources of trusted 331 information about COVID-19 vaccines?

We assessed the use of media as an information source by asking 'In the past 30 days, where have 334 you obtained information about COVID-19 vaccines?

Although television had high penetration 338 as an information source, its use tracked with education. The odds of receiving your information 440 important. An important limitation is that our survey was not designed to evaluate complacency 441 or hesitancy in-depth. We observed that as many as 16.4% of participants indicated that they 'Do 442 not see need for vaccine'. Complacency has been described as a major barrier in Africa and may 443 become increasingly important as milder variants of SARS-CoV-2 emerge and seroprevalence 444 from natural infection increases(33). We also did not specifically survey healthcare workers who 445 in some settings may be key drivers of vaccine hesitancy

The study data highlights the need for consistent and targeted information that is gender and age 452 specific and targeted to subpopulations such as PLWH. Information must be delivered by trusted 453 sources such as the Ministry of Health via traditional media platforms such as radio and television 454 that are heavily accessed and can be used to address misinformation delivered on social media

The vaccination encounter should equip friends and family with accurate information on specific 456 vaccines and side effects so they can act as informed social influencers for their family and friends

These individuals can be key ambassadors for vaccination within their social network. In addition, 458 educating religious leaders who have influence over their congregations and are key sources of 459 information, particularly among women, will be important. Vaccine hesitancy can only be tackled

WHO Coronavirus (COVID-19) Dashboard

/: WHO; 2022. 475 2. Organization WH. COVID-19 vaccine tracker and landscape

Organization WH. COVID-19 Vaccines

Challenges in ensuring global access to COVID-19 vaccines: 483 production, affordability, allocation, and deployment

Mapping 488 global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-489 scale retrospective temporal modelling study

COVID-19 vaccine acceptance and hesitancy in low-and middle-income countries

COVID-19 Vaccination bulletin

Achieving 70% COVID-19 Immunization Coverage by Mid-497 2022

Will Africans take COVID-19 vaccination?

Theory of Reasoned Action, Theory of Planned Behavior, and 507 the Integrated Behavioral Model

Social learning theory and the Health 510 Belief Model

The State of Vaccine Confidence

Reviews of evidence regarding interventions to improve vaccination coverage in 516 children, adolescents, and adults. The Task Force on Community Preventive Services

Benefits of pharmacist-led flu 519 vaccination services in community pharmacy

Promoting COVID-19 vaccine acceptance: recommendations from the Lancet 522 Commission on Vaccine Refusal, Acceptance, and Demand in the USA

Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study

Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated 529 against COVID-19 in France during the pandemic

Trends in 531 COVID-19 Vaccination Intent, Determinants and Reasons for Vaccine Hesitancy: 532 Results from Repeated Cross-Sectional Surveys in the Adult General Population of

Greece during

COVID-19 vaccination 535 for pregnant women in Zimbabwe: A public health challenge that needs an urgent 536 discourse

The anti-vaccination infodemic on social media: 538 A behavioral analysis

Associations between 542 HIV infection and clinical spectrum of COVID-19: a population level analysis based on 543 US National COVID Cohort Collaborative (N3C) data

Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 547 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective 548 cohort study

CoV-2 Variants in Patients with Immunosuppression

COVID-19 Vaccination Rates in a Global HIV Cohort

COVID-19 Related Medical Mistrust, Health Impacts, and Potential Vaccine Hesitancy 556 Among Black Americans Living With HIV

Guidelines for managing advanced HIV disease and rapid 559 initiation of antiretroviral therapy 560

Parents' uptake of human papillomavirus vaccines for their children: a systematic 563 review and meta-analysis of observational studies

Social media and vaccine hesitancy

Pandemic preparedness and COVID-19: an exploratory 567 analysis of infection and fatality rates, and contextual factors associated with 568 preparedness in 177 countries

Risk perception of COVID-19 among sub-Sahara Africans: a web-based comparative 571 survey of local and diaspora residents

COVID-19 573 vaccine hesitancy among Ethiopian healthcare workers

COVID-19 vaccine acceptance and hesitancy among healthcare workers 577 in South Africa